Amryt公司$Amryt Pharma(AMYT)$ 以其以低廉的价格收购昂贵的罕见疾病药物而闻名,它以全股票交易的方式获得了Chiasma及其肢端肥大症药物Mycapssa(奥曲肽)胶囊--以每股Chiasma股票交换0.39...查看全文
chuminhua2020-08-13 22:34
8/12,Chiasma$Chiasma(CHMA)$ 花了四年的时间将其肢端肥大的药Mycapssa从死里复活,现在药物又获得了一项扩展研究的积极结果的支持。该研究之前支持批准的36周研究的扩展研究,前48周的数据显示,药物可使受试者的肢体和器官生长,且无任何重大安全性问题。查看全文
薛定锷之猫2020-07-16 08:45
$Chiasma(CHMA)$
6月26,Octreotide的缓释口服胶囊MYCAPSSA获FDA批准,主治胃肠(手术)出血,以前的Octreotide是注射型。新瓶装旧酒,副作用一堆,获批后股价不涨反跌。
7月1号,增发$70M的股票,每股增发价4块,机构折扣价3.75,到今天15号(2周)还没见增发完成公告。
CEO(3)自...查看全文
chuminhua2020-07-02 15:39
$Chiasma(CHMA)$ 6/26,大约4年前,出于对后期关键性试验设计的担忧,FDA拒绝了Chiasma的Mycapssa (奥曲肽) 治疗肢端肥大症。现在,这个药物已经获得批准,成为首个FDA批准用于该适应症的口服疗法。Mycapssa表示,药物标价为起始剂量40mg,28天疗程5,152美元。查看全文
逍遥谷-百奥生2020-06-23 04:50
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions 翻译转自网页链接
不通之处,请自行翻译
从PDUFA日期开始,本周是繁忙的一周,FDA批准了默克公司(NYSE:MRK)和诺华制药(NYSE:NVS)等公司的批准...查看全文
Replix锐璞美股2020-01-31 00:40
肢端肥大症患者对$Chiasma(CHMA)$ 的Octreotide口服药相当期待,Octreotide的上市路也就差临门一脚了:6月份FDA就会公布审评结果,公司是否会像其它公司那样在审批结果之前开启上涨模式呢?请查阅我们详细的估值分析报告:网页链接。
$Black Diamond(BDTX)$ ...查看全文
$Chiasma(CHMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-21-027332 Act: 33 Size: 21 KB 网页链接
$Chiasma(CHMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-21-027333 Act: 33 Size: 21 KB 网页链接
$Chiasma(CHMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-21-027334 Act: 33 Size: 21 KB 网页链接
$Chiasma(CHMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-21-027335 Act: 33 Size: 21 KB 网页链接
$Chiasma(CHMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-21-027336 Act: 33 Size: 21 KB 网页链接
$Chiasma(CHMA)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001140361-21-027324 Act: 33 Size: 18 KB 网页链接
$Chiasma(CHMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-050040 Size: 31 KB 网页链接
$Chiasma(CHMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-050039 Size: 22 KB 网页链接
$Chiasma(CHMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-050037 Size: 21 KB 网页链接
$Chiasma(CHMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-050038 Size: 23 KB 网页链接